Lambert, Gilles
Inserm · University of Reunion Island
15 papers on CoChatORCID 0000-0001-5632-0685
Most cited papers
- Verified
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell
Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism
Cited by 1,819
- Verified
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal
Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases
Cited by 1,449
- Verified
Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis
Hayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology
Liver physiology and pathologyCholesterol and Lipid Metabolism
Cited by 1,107
- Verified
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications
MicroRNA in disease regulationCholesterol and Lipid Metabolism
Cited by 428
- Verified
The metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research
Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health
Cited by 331
- Verified
Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity
Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry
Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism
Cited by 312
- Verified
Inhibiting PCSK9 — biology beyond LDL control
Stoekenbroek, R. M., Lambert, G., Cariou, B., & Hovingh, G. K. (2019) · Nature Reviews Endocrinology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 141
- Verified
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab
Thedrez, A., Blom, D. J., Ramin-Mangata, S., Blanchard, V., Croyal, M., Chemello, K., Nativel, B., Pichelin, M., Cariou, B., Bourane, S., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 105
- Verified
Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells
Lalanne, F., Lambert, G., Amar, M. J. A., Chétiveaux, M., Zaïr, Y., Jarnoux, A.-L., Ouguerram, K., Friburg, J., Seidah, N. G., Brewer, H. B., et al. (2005) · Journal of Lipid Research
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 104
- Verified
Peroxisome Proliferator-activated Receptor β/δ Regulates Very Low Density Lipoprotein Production and Catabolism in Mice on a Western Diet
Akiyama, T. E., Lambert, G., Nicol, C. J., Matsusue, K., Peters, J. M., Brewer, H. B., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry
Peroxisome Proliferator-Activated ReceptorsLipid metabolism and disorders
Cited by 97
- Verified
Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice
Yim, S. H., Shah, Y., Tomita, S., Morris, D. H., Gavrilova, O., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2006) · Hepatology
Liver physiology and pathologyAngiogenesis and VEGF in Cancer
Cited by 49
- Verified
A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes
Loregger, A., Cook, E. C. L., Nelson, J. K., Moeton, M., Sharpe, L. J., Engberg, S., Karimova, M., Lambert, G., Brown, A. J., & Zelcer, N. (2016) · Molecular and Cellular Biology
Cholesterol and Lipid MetabolismCancer, Lipids, and Metabolism
Cited by 48
- Verified
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study
Blanchard, V., Ramin-Mangata, S., Billon-Crossouard, S., Aguesse, A., Durand, M., Chemello, K., Nativel, B., Flet, L., Chétiveaux, M., Jacobi, D., et al. (2018) · Journal of Lipid Research
Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health
Cited by 43
- Verified
PCSK9 and the nervous system: a no-brainer?
Jaafar, A. K., Techer, R., Chemello, K., Lambert, G., & Bourane, S. (2023) · Journal of Lipid Research
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 35
- Verified
Low levels of low-density lipoprotein-C associated with proprotein convertase subtilisin kexin 9 inhibition do not increase the risk of hemorrhagic transformation
Tran-Dinh, A., Levoye, A., Lambert, G., Louedec, L., Journé, C., Meilhac, O., & Amarenco, P. (2014) · Stroke
Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free